UnitedHealth Group Incorporated (NYSE:UNH) was the recipient of some unusual options trading activity on Friday. Traders acquired 5,895 put options on the stock. This is an increase of approximately 254% compared to the average daily volume of 1,667 put options.

A number of equities analysts recently commented on UNH shares. UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price objective for the company in a research note on Tuesday, May 30th. BidaskClub raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 8th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 28th. Finally, Vetr raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective for the company in a research note on Tuesday, May 30th. One analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $203.59.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same period last year, the business earned $1.96 EPS. UnitedHealth Group’s revenue for the quarter was up 7.7% compared to the same quarter last year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the sale, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders have sold 76,174 shares of company stock valued at $14,981,909 in the last ninety days. Insiders own 0.89% of the company’s stock.

A number of large investors have recently made changes to their positions in UNH. BlackRock Inc. grew its position in UnitedHealth Group by 1.2% during the 2nd quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares during the last quarter. Vanguard Group Inc. grew its position in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the last quarter. FMR LLC grew its position in UnitedHealth Group by 2.1% during the 2nd quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares during the last quarter. State Street Corp grew its position in UnitedHealth Group by 2.5% during the 1st quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after purchasing an additional 1,122,534 shares during the last quarter. Finally, Alliancebernstein L.P. grew its position in UnitedHealth Group by 2.3% during the 2nd quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after purchasing an additional 174,290 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/09/25/unitedhealth-group-target-of-unusually-large-options-trading-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.